SynthesisWorld journal of surgery2026
Outcomes After Intraoperative Hypovolemic Phlebotomy in Patients Undergoing Liver Surgery: A Meta-Analysis.
Synthesis in World journal of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe risk of blood loss in liver surgery remains a recent concern. Recent investigations have shown that intraoperative hypovolemic phlebotomy (HP) is effective at reducing blood loss and transfusions during liver surgery. In this meta-analysis, we seek to assess the effects of HP on patients undergoing liver surgery.
methodsElectronic databases, PubMed, Embase, and Web of Science, were searched from inception to January 2025, with an update in November 2025. Our eligibility criteria included randomized controlled trials (RCTs) or observational studies comparing HP to standard care in patients undergoing liver surgery. A random effects model was used for analysis pooling the mean differences (MD) and risk ratios (RRs) with corresponding 95% confidence intervals (CIs).
resultsA total of 13 studies, with 4577 patients, were analyzed. Compared with the control group, the use of HP was associated with a lower incidence of perioperative RBC transfusion (RR: 0.55, 95% CI: [0.46 to 0.67], p < 0.0001, and I
conclusionAmong patients undergoing liver surgery, the use of HP was associated with a lower blood transfusion rate and blood loss, while maintaining an acceptable safety profile. Further large clinical trials are necessary to clarify the exact mechanism involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.